Hugel Inc
Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults… Read more
Hugel Inc (145020) - Total Assets
Latest total assets as of September 2025: ₩1.03 Trillion KRW
Based on the latest financial reports, Hugel Inc (145020) holds total assets worth ₩1.03 Trillion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hugel Inc - Total Assets Trend (2014–2024)
This chart illustrates how Hugel Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hugel Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Hugel Inc's total assets of ₩1.03 Trillion consist of 55.7% current assets and 44.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩130.14 Billion | 13.9% |
| Accounts Receivable | ₩48.37 Billion | 5.2% |
| Inventory | ₩42.65 Billion | 4.5% |
| Property, Plant & Equipment | ₩150.97 Billion | 16.1% |
| Intangible Assets | ₩109.74 Billion | 11.7% |
| Goodwill | ₩86.18 Billion | 9.2% |
Asset Composition Trend (2014–2024)
This chart illustrates how Hugel Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hugel Inc's current assets represent 55.7% of total assets in 2024, an increase from 53.7% in 2014.
- Cash Position: Cash and equivalents constituted 13.9% of total assets in 2024, down from 17.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 16.1% of total assets.
Hugel Inc Competitors by Total Assets
Key competitors of Hugel Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Hugel Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hugel Inc generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Hugel Inc generates $ 14.46 in net profit.
Hugel Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.42 | 10.62 | 15.27 |
| Quick Ratio | 6.79 | 9.78 | 14.74 |
| Cash Ratio | 0.00 | 3.51 | 0.00 |
| Working Capital | ₩533.47 Billion | ₩ 500.56 Billion | ₩ 624.63 Billion |
Hugel Inc - Advanced Valuation Insights
This section examines the relationship between Hugel Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.98 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.1% |
| Total Assets | ₩939.44 Billion |
| Market Capitalization | $929.14 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hugel Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hugel Inc's assets grew by 1.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hugel Inc (2014–2024)
The table below shows the annual total assets of Hugel Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩939.44 Billion | +1.10% |
| 2023-12-31 | ₩929.25 Billion | -11.48% |
| 2022-12-31 | ₩1.05 Trillion | +3.97% |
| 2021-12-31 | ₩1.01 Trillion | +5.58% |
| 2020-12-31 | ₩956.34 Billion | +6.89% |
| 2019-12-31 | ₩894.69 Billion | -2.57% |
| 2018-12-31 | ₩918.27 Billion | +11.86% |
| 2017-12-31 | ₩820.93 Billion | +178.94% |
| 2016-12-31 | ₩294.30 Billion | +26.00% |
| 2015-12-31 | ₩233.57 Billion | +140.18% |
| 2014-12-31 | ₩97.25 Billion | -- |